A descriptive analysis of prevalent vs incident cervical intraepithelial neoplasia grade 3 following minor cytologic abnormalities

American Journal of Clinical Pathology

Volumn 138, Issue 2, 2012, Pages 241-246

  Castle, Philip E ^a   Gravitt, Patti E ^b   Wentzensen, Nicolas ^c   Schiffman, Mark ^c  

^a American Society for Clinical Pathology Institute   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cervical intraepithelial neoplasia (CIN); Cytology; Human papillomavirus (HPV); Pap

Indexed keywords

VIRUS DNA;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ARTICLE; ATYPICAL SQUAMOUS CELL OF UNDETERMINED SIGNIFICANCE; CANCER CYTODIAGNOSIS; CANCER GRADING; COLPOSCOPY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CYTOPATHOLOGY; DESCRIPTIVE RESEARCH; DNA DETERMINATION; EMERGENCY HEALTH SERVICE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; INCIDENTALOMA; LABORATORY DEVICE; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM GRADING; PREVALENCE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84865418279     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPNTK6G2PXWHOO     Document Type: Article

References (24)

1. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907. (Pubitemid 47371147)
2. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9:425-434.
3. Castle PE, Fetterman B, Akhtar I, et al. Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol. 2009;114:365-369.
4. Schiffman M, Rodriguez AC. Heterogeneity in CIN3 diagnosis. Lancet Oncol 2008;9:404-406. (Pubitemid 351618081)
5. Sherman ME, Wang SS, Tarone R, et al. Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the Atypical Squamous Cells of Undetermined Significance Low-grade Squamous Intraepithelial Lesion Triage Study: implications for subject safety and lead-time bias. Cancer Epidemiol Biomarkers Prev. 2003;12:372-379. (Pubitemid 36427999)
6. Schiffman M, Adrianza ME. ASCUS-LSIL Triage Study: design, methods and characteristics of trial participants. Acta Cytol 2000;44:726-742.
7. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 2000;92:397-402.
8. ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393-1400.
9. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003;188:1383-1392.
10. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-299. (Pubitemid 32219816)
11. Kurman RJ, Malkasian GD Jr., Sedlis A, et al. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification. Obstet Gynecol. 1991;77:779-782.
12. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119. (Pubitemid 34437346)
13. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38:357-361. (Pubitemid 30043317)
14. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis. 2001;183:1554-1564. (Pubitemid 32466692)
15. Schiffman M, Wheeler CM, Dasgupta A, et al. A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal Papanicolaou smears. Am J Clin Pathol. 2005;124:722-732. (Pubitemid 41532507)
16. Castle PE, Gravitt PE, Solomon D, et al. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol. 2008;46:109-117.
17. Castle PE, Schiffman M, Wheeler CM, et al. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiol Biomarkers Prev. 2010;19:1675-1681.
18. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens, part B: biological agents. Lancet Oncol 2009;10:321-322.
19. de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048-1056.
20. Pretorius RG, Zhang WH, Belinson JL, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol. 2004;191:430-434. (Pubitemid 39178694)
21. Jeronimo J, Schiffman M. Colposcopy at a crossroads. Am J Obstet Gynecol. 2006;195:349-353. (Pubitemid 44160679)
22. Kinney WK, Manos MM, Hurley LB, et al. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol. 1998;91:973-976. (Pubitemid 28246934)
23. Castle PE, Fetterman B, Thomas CJ, et al. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer. Obstet Gynecol 2010;116:76-84.
24. Gage JC, Hanson VW, Abbey K, et al. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006;108:264-272. (Pubitemid 44305665)